These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31382296)

  • 21. Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Jobanputra R; Dankó K
    Acta Reumatol Port; 2015; 40(4):337-47. PubMed ID: 26922197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies].
    Kowalska-Oledzka E; Stern LZ
    Neurol Neurochir Pol; 2000; 34(2):339-47. PubMed ID: 10962726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory Myopathies: Utility of Antibody Testing.
    Biliciler S; Kwan J
    Neurol Clin; 2020 Aug; 38(3):661-678. PubMed ID: 32703475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018.
    Mammen AL; Allenbach Y; Stenzel W; Benveniste O;
    Neuromuscul Disord; 2020 Jan; 30(1):70-92. PubMed ID: 31791867
    [No Abstract]   [Full Text] [Related]  

  • 27. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
    Mandel DE; Malemud CJ; Askari AD
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis.
    Krajnc I
    Adv Exp Med Biol; 1999; 455():181-6. PubMed ID: 10599341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired inflammatory myopathies: interest of specific autoantibodies for their classification].
    Benveniste O
    Rev Prat; 2015 May; 65(5):607-12. PubMed ID: 26165090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New autoantibodies in dermatomyositis].
    Bielsa I
    Actas Dermosifiliogr; 2009 Apr; 100(3):182-9. PubMed ID: 19457303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoantibodies of Inflammatory Myopathies: Update].
    Suzuki S
    Brain Nerve; 2016 Dec; 68(12):1443-1451. PubMed ID: 27916754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification and management of adult inflammatory myopathies.
    Selva-O'Callaghan A; Pinal-Fernandez I; Trallero-Araguás E; Milisenda JC; Grau-Junyent JM; Mammen AL
    Lancet Neurol; 2018 Sep; 17(9):816-828. PubMed ID: 30129477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
    Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
    Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of myositis.
    Lundberg IE; de Visser M; Werth VP
    Nat Rev Rheumatol; 2018 May; 14(5):269-278. PubMed ID: 29651121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Idiopathic inflammatory myopathies].
    Vencovský J
    Vnitr Lek; 2018; 64(2):155-163. PubMed ID: 29595280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab in the treatment of inflammatory myopathies: a review.
    Fasano S; Gordon P; Hajji R; Loyo E; Isenberg DA
    Rheumatology (Oxford); 2017 Jan; 56(1):26-36. PubMed ID: 27121778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.